Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection.

"Conflict of interest: B.B.: consultant/advisor: Abbott, Bioline Supply, Crosstec GmbH, Kapamed, Kimal PLC, M3 Medical/Ecclipse Medical, Medival SRL, Philips/Spectranetics, Sintec SRL, Tauro-Implant GmbH, Tauropharm GmbH, Transcutan; the other authors declare no conflict of interest in relation to this manuscript."

"Funding S.B.: research grant through his employer from the manufacturer of TauroPace™. B.B.: consultant/advisor: manufacturer of TauroPace™, Kimal plc, Kapamed, Crosstec, Bioline Supply, MCM Ag, Tauro-Implant, Medival SRL, Spectranetics, Abbott. J.M.: received a research grant through her employer from the manufacturer of TauroPace™. R.V.: research grant through his employer from the manufacturer of TauroPace™. Tauropharm funded open access for this manuscript."

"Clinical trial registration ClinicalTrials.gov Identifier: NCT05576194"